Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Zanamivir | |
Synonyms |
|
|
Definitions |
A sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sialic acid residues in host cell membrane-bound glycoprotein receptors for influenza viruses, preventing the release of progeny viruses from host cell surfaces and, so, further viral replication. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C47786 |
|
ALT_DEFINITION |
A drug used to prevent and to treat influenza virus infections. It blocks the release of the virus from infected cells. It is a type of antiviral agent.
|
|
CAS_Registry |
139110-80-8
|
|
CHEBI_ID |
CHEBI:50663
|
|
Chemical_Formula |
C12H20N4O7
|
|
code |
C47786
|
|
Contributing_Source |
CTRP FDA
|
|
definition |
A sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sialic acid residues in host cell membrane-bound glycoprotein receptors for influenza viruses, preventing the release of progeny viruses from host cell surfaces and, so, further viral replication.
|
|
Display_Name |
Zanamivir
|
|
FDA_UNII_Code |
L6O3XI777I
|
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
label |
Zanamivir
|
|
Legacy Concept Name |
Zanamivir
|
|
NCI_Drug_Dictionary_ID |
636195
|
|
PDQ_Closed_Trial_Search_ID |
636195
|
|
PDQ_Open_Trial_Search_ID |
636195
|
|
Preferred_Name |
Zanamivir
|
|
prefixIRI |
NCIT:C47786
|
|
prefLabel |
Zanamivir
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C0216660
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping